Carregant...

Targeting TFPI for hemophilia treatment

Hemophilia is a severe bleeding disorder treated by infusion of the missing blood coagulation protein, factor VIII or factor IX. The discovery and characterization of the anticoagulant protein tissue factor pathway inhibitor (TFPI) led to the realization that inhibition of TFPI activity could restor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thromb Res
Autors principals: Peterson, Julie A., Maroney, Susan A., Mast, Alan E.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950664/
https://ncbi.nlm.nih.gov/pubmed/27207418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0049-3848(16)30359-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!